Open Access · CC BY-NC-ND 4.0
Palbociclib real-world data collection to assess safety and efficacy in patients with metastatic HER2+ve breast cancer
The Royal College of Radiologists Open · 2023
DOI: 10.1016/j.rcro.2023.100014 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Royal College of Radiologists Open, 2023. Verfasst von Akram Ali und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ali, A., Zarroug, M., & Mahtab, N. (2023). Palbociclib real-world data collection to assess safety and efficacy in patients with metastatic HER2+ve breast cancer. The Royal College of Radiologists Open. https://doi.org/10.1016/j.rcro.2023.100014
Vancouver
Ali A, Zarroug M, Mahtab N. Palbociclib real-world data collection to assess safety and efficacy in patients with metastatic HER2+ve breast cancer. The Royal College of Radiologists Open. 2023. doi:10.1016/j.rcro.2023.100014
BibTeX
@article{Ali2023,
author = {Ali, Akram and Zarroug, Maha and Mahtab, Najibah},
title = {Palbociclib real-world data collection to assess safety and efficacy in patients with metastatic HER2+ve breast cancer},
journal = {The Royal College of Radiologists Open},
year = {2023},
doi = {10.1016/j.rcro.2023.100014}
}
EUVIMED